Extended daily dialysis

Management of Acute Kidney Problems

Volumn , Issue , 2010, Pages 537-545

  Fliser, Danilo ^a   Kielstein, Jan T ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873612339     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-69441-0_53     Document Type: Chapter

References (47)

1. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20
2. Alam M, Marshall M, Shaver M, Chatoth D: Cost comparison between sustained low efficiency hemodialysis (SLED) and continuous venovenous hemofiltration (CVVH) for ICU patients with ARF. Am J Kidney Dis 2000;35:A9
3. Augustine JJ, Sandy D, Seifert TH, Paganini EP: A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004;44: 1000-1007
4. Barenbrock M, Hausberg M, Matzkies F, De la MS, Schaefer RM: Effects of bicarbonate-and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 2000;58:1751-1757
5. Berbece AN, Richardson RM: Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation, and solute removal. Kidney Int 2006;70:963-968
6. Burkhardt O, Joukhadar C, Traunmuller F, Hadem J, Welte T, Kielstein JT: Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 2008;61:224-225
7. Czock D, Husig-Linde C, Langhoff A, Schoepke T, Hafer C, deGroot K, Swoboda S, Kuse E, Haller H, Fliser D, Keller F, Kielstein JT: Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 2006;1:1263-1268
8. Davenport A, Bouman C, Kirpalani A, Skippen P, Tolwani A, Mehta RL, Palevsky PM: Delivery of renal replacement therapy in acute kidney injury: What are the key issues? Clin J Am Soc Nephrol 2008;3:864-868
9. Dhondt A, Verstraete A, Vandewoude K, Segers H, Eloot S, Decruyenaere J, Vanholder R: Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: The case of lithium intoxication therapy. Am J Kidney Dis 2005;46:e95-e99
10. Eloot S, Van Biesen W, Dhondt A, Van De WH, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2007
11. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Sagripanti S, Manini P, Andreoli R, Cabassi A: Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 2004;32:2437-2442
12. Fliser D, Kielstein JT: A single-pass batch dialysis system: An ideal dialysis method for the patient in intensive care with acute renal failure. Curr Opin Crit Care 2004;10:483-488
13. Golper TA: Hybrid renal replacement therapies for critically ill patients. Contrib Nephrol 2004;144:278-283
14. Hall FS, Shaver MJ, Marshall MR: Daily 12-hour sustained low-efficiency hemodialysis (SLED): A nursing perspective. Blood Purif 1999;17:36A.
15. Kanagasundaram NS, Larive AB, Paganini EP: A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 2003;59:47-55
16. Kielstein JT, Boger RH, Bode-Boger SM, Martens-Lobenhoffer J, Lonnemann G, Frolich JC, Haller H, Fliser D: Low dialysance of asymmetric dimethylarginine (ADMA) -in vivo and in vitro evidence of significant protein binding. Clin Nephrol 2004;62:295-300
17. Kielstein JT, Czock D, Schopke T, Hafer C, Bode-Boger SM, Kuse E, Keller F, Fliser D: Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 2006;34:51-56
18. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D: Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomized controlled study. Am J Kidney Dis 2004;43:342-349
19. Kielstein JT, Linnenweber S, Schoepke T, Fliser D: One for all -a multi-use dialysis system for effective treatment of severe thallium intoxication. Kidney Blood Press Res 2004; 27:197-199
20. Kielstein JT, Schwarz A, Arnavaz A, Sehlberg O, Emrich HM, Fliser D: High-flux hemodialysis -an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 2002;57:484-486
21. Kielstein JT, Stadler M, Czock D, Keller F, Hertenstein B, Radermacher J: Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 2005;74:533-534
22. Kielstein JT, Woywodt A, Schumann G, Haller H, Fliser D: Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol 2003;41: 873-876
23. Kolff WJ: Lasker Clinical Medical Research Award. The artificial kidney and its effect on the development of other artificial organs. Nat Med 2002;8:1063-1065
24. Kumar VA, Craig M, Depner TA, Yeun JY: Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000;36:294-300
25. Kumar VA, Yeun JY, Depner TA, Don BR: Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: A two-year single center report. Int J Artif Organs 2004;27:371-379
26. Lameire N, Van Biesen W, Vanholder R: Dialysing the patient with acute renal failure in the ICU: The emperor's clothes? Nephrol Dial Transplant 1999;14:2570-2573
27. Liao Z, Zhang W, Hardy PA, Poh CK, Huang Z, Kraus MA, Clark WR, Gao D: Kinetic comparison of different acute dialysis therapies. Artif Organs 2003;27:802-807
28. Lonnemann G, Floege J, Kliem V, Brunkhorst R, Koch KM: Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant 2000;15:1189-1193
29. Ma, T., Walker, J. A., Eggleton, K., and Marshall, M. Cost comparison between sustained low efficiency daily dialysis/ diafiltration (SLEDD) and continuous renal replacement therapy for ICU patients with ARF. Nephrology (Carlton.) 7, A54. 2002. Ref type: Abstract
30. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001;60:777-785
31. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002;39:556-570
32. Marshall MR, Golper TA, Shaver MJ, Chatoth DK: Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 2001;252-257
33. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB: Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: Towards an adequate therapy. Nephrol Dial Transplant 2004;19:877-884
34. Mehta RL, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM, Chertow GM: Nephrology consultation in acute renal failure: Does timing matter? Am J Med 2002;113:456-461
35. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004;66:1613-1621
36. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le G, Jr., Druml W: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-2058
37. Morgera S, Scholle C, Melzer C, Slowinski T, Liefeld L, Baumann G, Peters H, Neumayer HH: A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 2004;98:c35-c40
38. Naka T, Baldwin I, Bellomo R, Fealy N, Wan L: Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 2004;27:380-387
39. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatori G, Andrikos E, Yavuz A, Crepaldi C, Ronco C: Phosphate kinetics during different dialysis modalities. Blood Purif 2005;23:83-90
40. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000;356:26-30
41. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346: 305-310
42. Schlaeper C, Amerling R, Manns M, Levin NW: High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 1999;72: S20-S23
43. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, Lemaire F, Brochard L: Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: Usefulness of practice guidelines. Am J Respir Crit Care Med 2000;162:197-202
44. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM: Standard versus high-dose CVVHDF for ICUrelated acute renal failure. J Am Soc Nephrol 2008;19: 1233-1238
45. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818
46. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ: Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005;20:1630-1637
47. Van Der Sande FM, Kooman JP, Konings CJ, Leunissen KM: Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: The effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001;12:1916-1920